BioArctic AB is a Swedish biotechnology company developing drugs for neurodegenerative diseases, including Alzheimer's and Parkinson's. The company is known for its disease-modifying treatment Leqembi® and collaborates with global pharmaceutical companies. BioArctic was founded in 2003 and is headquartered in Stockholm.
Kategori
All
Hot Chair
2022-11-10
Oskar Bosson, Investor Relations & Communications at BioArctic, talks about BioArctic's impressive progress, the partnership with Eisai and the great interest in the drug candidate Lecanemab.
Select your language:
